TORONTO, December 2 – Acumyn is proud to announce an exclusive agreement with Elekta to commercialize its integrated Quality Management System, AQUA. The system enables multiple mechanical, dosimetric and imaging QA tests to be conducted, analyzed and reported across the radiotherapy clinic.
Ferhan Bulca, Chief Executive Officer at Acumyn says: “Elekta is the ideal partner to Acumyn to deliver AQUA to clinics and hospitals globally. Acumen’s expertise in research and development of quality control and management software is complemented by Elekta’s global customer base in radiation therapy.”
In collaboration with Princess Margaret Cancer Centre in Toronto, Elekta has developed a specialized version of the AQUA system, which is based on a system version that has been in use for over a year, connecting more than 20 machines.
Bulca says: “AQUA is a proven department-level device quality control and management software that has been in daily operations at Princess Margaret Cancer Centre, one of top-five cancer research centres in the world.”
Dee Mathieson, Senior Vice President, Oncology Business Line Management at Elekta adds: “Because AQUA has been developed from a QMS already in clinical practice, it very closely matches the practical, day-to-day requirements of our customers. The system follows Elekta’s open source philosophy and will seamlessly link a range of equipment – regardless of vendor – throughout a typical radiotherapy department.”
AQUA will initially be piloted at selected sites before it is added to Elekta’s commercial portfolio.
Acumyn is a spin-off company from Princess Margaret Cancer Centre and University Health Network, Toronto, Ontario, Canada. A highly focused research and development company, Acumyn is commercializing a department-level machine quality control software platform for radiation therapy devices. With its software platform, Acumyn helps clinics provide radiation therapy treatment with full confidence, enabling clinicians to cure more cancer patients than ever before by exploiting full performance potential of their devices and using high-precision techniques. Website: www.acumyn.com.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elect employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com